NCT01515020View on ClinicalTrials.gov

Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2014

Conditions
Nosocomial InfectionHealthcare-associated Infection
Interventions
DRUG

vancomycin monotherapy

intravenous therapy by vancomycin

DRUG

daptomycin monotherapy

intravenous therapy by daptomycin

Trial Locations (1)

92118

Hopital Beaujon, Clichy

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01515020 - Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia | Biotech Hunter | Biotech Hunter